• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD
South and Central America In Vitro Diagnostics Market Outlook to 2017- Clinical Chemistry Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture - Product Image

South and Central America In Vitro Diagnostics Market Outlook to 2017- Clinical Chemistry Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture

  • ID: 2016445
  • January 2012
  • Region: America, Central America
  • 139 pages
  • GlobalData

FEATURED COMPANIES

  • Abbott Laboratories
  • Beckman Coulter, Inc.
  • DIAGNOSTICA STAGO, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Grifols, S.A.
  • PerkinElmer, Inc.
  • MORE

South and Central America In Vitro Diagnostics Market Outlook to 2017- Clinical Chemistry Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture

Summary

GlobalData’s new report, “South and Central America In Vitro Diagnostics Market Outlook to 2017- Clinical Chemistry Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture” provides key market data on the South and Central America In Vitro Diagnostics market – Argentina, Brazil and Mexico. The report provides value (USD million) data for all the market categories – Clinical Chemistry, Genetic Testing, Haematology, Histology And Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s READ MORE >

FEATURED COMPANIES

  • Abbott Laboratories
  • Beckman Coulter, Inc.
  • DIAGNOSTICA STAGO, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Grifols, S.A.
  • PerkinElmer, Inc.
  • MORE

1
1

1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 What is This Report About?
3 In Vitro Diagnostics in South and Central America
3.1 In Vitro Diagnostics Cross Country Comparison, USD Actual, 2003-2017
3.2 In Vitro Diagnostics, South and Central America, Overall Revenue ($m), USD Actual, 2003-2017
3.3 In Vitro Diagnostics, South and Central America, Company share (2009-2010)
4 In Vitro Diagnostics In Brazil
4.1 In Vitro Diagnostics, Brazil, Overall Revenue ($m), USD Actual, 2003-2017
4.2 In Vitro Diagnostics, Brazil, Distribution Share (2009-2010)
4.2.1 Clinical Chemistry, Brazil, Distribution Share (2009-2010)
4.2.2 Genetic Testing , Brazil, Distribution Share (2009-2010)
4.2.3 Haematology , Brazil, Distribution Share (2009-2010)
4.2.4 Histology And Cytology , Brazil, Distribution Share (2009-2010)
4.2.5 Immuno Chemistry , Brazil, Distribution Share (2009-2010)
4.2.6 Infectious Immunology , Brazil, Distribution Share (2009-2010)
4.2.7 Microbiology Culture , Brazil, Distribution Share (2009-2010)
4.3 In Vitro Diagnostics, Brazil, Company share (2009-2010)
4.3.1 In Vitro Diagnostics, Brazil, Company share (2009-2010)
4.3.2 Clinical Chemistry, Brazil, Company share (2009-2010)
4.3.3 Genetic Testing, Brazil, Company share (2009-2010)
4.3.4 Haematology, Brazil, Company share (2009-2010)
4.3.5 Histology And Cytology, Brazil, Company share (2009-2010)
4.3.6 Immuno Chemistry, Brazil, Company share (2009-2010)
4.3.7 Infectious Immunology, Brazil, Company share (2009-2010)
4.3.8 Microbiology Culture, Brazil, Company share (2009-2010)
5 In Vitro Diagnostics In Argentina
5.1 In Vitro Diagnostics, Argentina, Overall Revenue ($m), USD Actual, 2003-2017
5.2 In Vitro Diagnostics, Argentina, Distribution Share (2009-2010)
5.2.1 Clinical Chemistry , Argentina, Distribution Share (2009-2010)
5.2.2 Genetic Testing , Argentina, Distribution Share (2009-2010)
5.2.3 Haematology , Argentina, Distribution Share (2009-2010)
5.2.4 Histology and Cytology , Argentina, Distribution Share (2009-2010)
5.2.5 Immuno Chemistry , Argentina, Distribution Share (2009-2010)
5.2.6 Infectious Immunology , Argentina, Distribution Share (2009-2010)
5.2.7 Microbiology Culture , Argentina, Distribution Share (2009-2010)
5.3 In Vitro Diagnostics, Argentina, Company share (2009-2010)
5.3.1 In Vitro Diagnostics, Argentina, Company share (2009-2010)
5.3.2 Clinical Chemistry, Argentina, Company share (2009-2010)
5.3.3 Genetic Testing, Argentina, Company share (2009-2010)
5.3.4 Haematology, Argentina, Company share (2009-2010)
5.3.5 Histology and Cytology, Argentina, Company share (2009-2010)
5.3.6 Immuno Chemistry, Argentina, Company share (2009-2010)
5.3.7 Infectious Immunology, Argentina, Company share (2009-2010)
5.3.8 Microbiology Culture, Argentina, Company share (2009-2010)
6 In Vitro Diagnostics In Mexico
6.1 In Vitro Diagnostics, Mexico, Overall Revenue ($m), USD Actual, 2003-2017
6.2 In Vitro Diagnostics, Mexico, Distribution Share (2009-2010)
6.2.1 Clinical Chemistry, Mexico, Distribution Share (2009-2010)
6.2.2 Genetic Testing, Mexico, Distribution Share (2009-2010)
6.2.3 Haematology, Mexico, Distribution Share (2009-2010)
6.2.4 Histology And Cytology, Mexico, Distribution Share (2009-2010)
6.2.5 Immuno Chemistry, Mexico, Distribution Share (2009-2010)
6.2.6 Infectious Immunology, Mexico, Distribution Share (2009-2010)
6.2.7 Microbiology Culture, Mexico, Distribution Share (2009-2010)
6.3 In Vitro Diagnostics, Mexico, Company Share (2009-2010)
6.3.1 In Vitro Diagnostics, Mexico, Company Share (2009-2010)
6.3.2 Clinical Chemistry, Mexico, Company Share (2009-2010)
6.3.3 Genetic Testing, Mexico, Company Share (2009-2010)
6.3.4 Haematology, Mexico, Company Share (2009-2010)
6.3.5 Histology And Cytology, Mexico, Company Share (2009-2010)
6.3.6 Immuno Chemistry, Mexico, Company Share (2009-2010)
6.3.7 Infectious Immunology, Mexico, Company Share (2009-2010)
6.3.8 Microbiology Culture, Mexico, Company Share (2009-2010)
7 Overview of Key Companies in South and Central America In Vitro Diagnostics Market
7.1 F. Hoffmann-La Roche Ltd.
7.1.1 Company Overview
7.1.2 Share in the South and Central America In Vitro Diagnostics Market
7.2 Siemens Healthcare
7.2.1 Company Overview
7.2.2 Share in the South and Central America In Vitro Diagnostics Market
7.3 Abbott Laboratories
7.3.1 Company Overview
7.3.2 Share in the South and Central America In Vitro Diagnostics Market
7.4 bioMerieux S.A.
7.4.1 Company Overview
7.4.2 Share in the South and Central America In Vitro Diagnostics Market
7.5 Bio-Rad Laboratories, Inc.
7.5.1 Company Overview
7.5.2 Share in the South and Central America In Vitro Diagnostics Market
7.6 Ortho-Clinical Diagnostics Inc.
7.6.1 Company Overview
7.6.2 Share in the South and Central America In Vitro Diagnostics Market
7.7 Beckman Coulter, Inc.
7.7.1 Company Overview
7.8 HORIBA, Ltd.
7.8.1 Company Overview
7.9 Becton, Dickinson and Company
7.9.1 Company Overview
7.10 Sysmex Corporation
7.10.1 Company Overview
7.11 Alere Inc.
7.11.1 Company Overview
7.12 DiaSorin S.p.A
7.12.1 Company Overview
7.13 Thermo Fisher Scientific Inc.
7.13.1 Company Overview
7.14 Phadia AB
7.14.1 Company Overview
7.15 Qiagen N.V.
7.15.1 Company Overview
7.16 Gen-Probe Incorporated
7.16.1 Company Overview
7.17 PerkinElmer, Inc.
7.17.1 Company Overview
7.18 Mindray Medical International Limited
7.18.1 Company Overview
7.19 Grifols, S.A.
7.19.1 Company Overview
7.20 DIAGNOSTICA STAGO, Inc.
7.20.1 Company Overview
8 In Vitro Diagnostics Market Pipeline Products
8.1 Clinical Chemisty Market Pipeline Products
8.2 Immuno Chemistry Market Pipeline Products
8.3 Haematology Market Pipeline Products
8.4 Infectious Immunology Market Pipeline Products
8.5 Microbiology Culture Market Pipeline Products
8.6 Histology and Cytology Market Pipeline Products
8.7 Genetic Testing Market Pipeline Products
9 Financial Deals Landscape
9.1 Partnerships
9.1.1 Enigma Diagnostics Enters Into Co-Development Agreement With GlaxoSmithKline
9.1.2 Myriad Genetics Enters Into Licensing Agreement With Chronix Biomedical
9.1.3 AmStem Announces Co-Marketing Agreement With Histostem
10 Appendix
10.1 Definitions of Markets Covered in the Report
10.1.1 In Vitro Diagnostics
10.2 Research Methodology
10.3 Secondary Research
10.4 Primary Research
10.5 Models
10.6 Forecasts
10.7 Expert Panels
10.8 GlobalData Consulting
10.9 Currency Conversion
10.10 Contact Us
10.11 Disclaimer

1.1 List of Tables
Table 1: In Vitro Diagnostics, Cross Country Comparison, USD Actual, 2003-2017
Table 2: In Vitro Diagnostics, South and Central America, Overall Revenue ($m), USD Actual, 2003-2017
Table 3: In Vitro Diagnostics, South and Central America, Cross-Category Analysis, 2003-2017
Table 4: In Vitro Diagnostics, South and Central America, Overall Revenue ($m), USD Actual, Historic, 2003-2010
Table 5: In Vitro Diagnostics, South and Central America, Overall Revenue ($m), USD Actual, Forecast, 2010-2017
Table 6: In Vitro Diagnostics, South and Central America, Company share by Revenue ($m), USD Actual, 2009-2010
Table 7: In Vitro Diagnostics, Brazil, Overall Revenue ($m), USD Actual, 2003-2017
Table 8: In Vitro Diagnostics, Brazil, Overall Revenue ($m), USD Actual, Historic, 2003-2010
Table 9: In Vitro Diagnostics, Brazil, Overall Revenue ($m), USD Actual, Forecast, 2010-2017
Table 10: Clinical Chemistry, Brazil, Distribution Share by Revenue ($m), USD Actual, 2009-2010
Table 11: Genetic Testing, Brazil, Distribution Share by Revenue ($m), USD Actual, 2009-2010
Table 12: Haematology, Brazil, Distribution Share by Revenue ($m), USD Actual, 2009-2010
Table 13: Histology And Cytology, Brazil, Distribution Share by Revenue ($m), USD Actual, 2009-2010
Table 14: Immuno Chemistry, Brazil, Distribution Share by Revenue ($m), USD Actual, 2009-2010
Table 15: Infectious Immunology, Brazil, Distribution Share by Revenue ($m), USD Actual, 2009-2010
Table 16: Microbiology Culture, Brazil, Distribution Share by Revenue ($m), USD Actual, 2009-2010
Table 17: In Vitro Diagnostics, Brazil, Company share by Revenue ($m), USD Actual, 2009-2010
Table 18: Clinical Chemistry, Brazil, Company share by Revenue ($m), USD Actual 2009-2010
Table 19: Genetic Testing, Brazil, Company share by Revenue ($m), USD Actual 2009-2010
Table 20: Haematology, Brazil, Company share by Revenue ($m), USD Actual 2009-2010
Table 21: Histology And Cytology, Brazil, Company share by Revenue ($m), USD Actual 2009-2010
Table 22: Immuno Chemistry, Brazil, Company share by Revenue ($m), USD Actual 2009-2010
Table 23: Infectious Immunology, Brazil, Company share by Revenue ($m), USD Actual 2009-2010
Table 24: Microbiology Culture, Brazil, Company share by Revenue ($m), USD Actual 2009-2010
Table 25: In Vitro Diagnostics, Argentina, Overall Revenue ($m), USD Actual, 2003-2017
Table 26: In Vitro Diagnostics, Argentina, Overall Revenue ($m), USD Actual, Historic, 2003-2010
Table 27: In Vitro Diagnostics, Argentina, Overall Revenue ($m), USD Actual, Forecast, 2010-2017
Table 28: Clinical Chemistry, Argentina, Distribution Share by Revenue ($m), USD Actual, 2009-2010
Table 29: Genetic Testing, Argentina, Distribution Share by Revenue ($m), USD Actual, 2009-2010
Table 30: Haematology, Argentina, Distribution Share by Revenue ($m), USD Actual, 2009-2010
Table 31: Histology And Cytology, Argentina, Distribution Share by Revenue ($m), USD Actual, 2009-2010
Table 32: Immuno Chemistry, Argentina, Distribution Share by Revenue ($m), USD Actual, 2009-2010
Table 33: Infectious Immunology, Argentina, Distribution Share by Revenue ($m), USD Actual, 2009-2010
Table 34: Microbiology Culture, Argentina, Distribution Share by Revenue ($m), USD Actual, 2009-2010
Table 35: In Vitro Diagnostics, Argentina, Company share by Revenue ($m), USD Actual, 2009-2010
Table 36: Clinical Chemistry, Argentina, Company share by Revenue ($m), USD Actual 2009-2010
Table 37: Genetic Testing, Argentina, Company share by Revenue ($m), USD Actual 2009-2010
Table 38: Haematology, Argentina, Company share by Revenue ($m), USD Actual 2009-2010
Table 39: Histology And Cytology, Argentina, Company Share by Revenue ($m), USD Actual 2009-2010
Table 40: Immuno Chemistry, Argentina, Company share by Revenue ($m), USD Actual 2009-2010
Table 41: Infectious Immunology, Argentina, Company share by Revenue ($m), USD Actual 2009-2010
Table 42: Microbiology Culture, Argentina, Company share by Revenue ($m), USD Actual 2009-2010
Table 43: In Vitro Diagnostics, Mexico, Overall Revenue ($m), USD Actual, 2003-2017
Table 44: In Vitro Diagnostics, Mexico, Overall Revenue ($m), USD Actual, Historic, 2003-2010
Table 45: In Vitro Diagnostics, Mexico, Overall Revenue ($m), USD Actual, Forecast, 2010-2017
Table 46: Clinical Chemistry, Mexico, Distribution Share by Revenue ($m), USD Actual, 2009-2010
Table 47: Genetic Testing, Mexico, Distribution Share by Revenue ($m), USD Actual, 2009-2010
Table 48: Haematology, Mexico, Distribution Share by Revenue ($m), USD Actual, 2009-2010
Table 49: Histology And Cytology, Mexico, Distribution Share by Revenue ($m), USD Actual, 2009-2010
Table 50: Immuno Chemistry, Mexico, Distribution Share by Revenue ($m), USD Actual, 2009-2010
Table 51: Infectious Immunology, Mexico, Distribution Share by Revenue ($m), USD Actual, 2009-2010
Table 52: Microbiology Culture, Mexico, Distribution Share by Revenue ($m), USD Actual, 2009-2010
Table 53: In Vitro Diagnostics, Mexico, Company Share by Revenue ($m), USD Actual, 2009-2010
Table 54: Clinical Chemistry, Mexico, Company Share by Revenue ($m), USD Actual 2009-2010
Table 55: Genetic Testing, Mexico, Company Share by Revenue ($m), USD Actual 2009-2010
Table 56: Haematology, Mexico, Company Share by Revenue ($m), USD Actual 2009-2010
Table 57: Histology And Cytology, Mexico, Company Share by Revenue ($m), USD Actual 2009-2010
Table 58: Immuno Chemistry, Mexico, Company Share by Revenue ($m), USD Actual 2009-2010
Table 59: Infectious Immunology, Mexico, Company Share by Revenue ($m), USD Actual 2009-2010
Table 60: Microbiology Culture, Mexico, Company Share by Revenue ($m), USD Actual 2009-2010
Table 61: Clinical Chemisty Market Pipeline Products
Table 62: Immuno Chemistry Market Pipeline Products
Table 63: Haematology Market Pipeline Products
Table 64: Infectious Immunology Market Pipeline Products
Table 65: Microbiology Culture Market Pipeline Products
Table 66: Histology and Cytology Market Pipeline Products
Table 67: Genetic Testing Market Pipeline Products
Table 68: Enigma Diagnostics Enters Into Co-Development Agreement With GlaxoSmithKline
Table 69: Myriad Genetics Enters Into Licensing Agreement With Chronix Biomedical
Table 70: AmStem Announces Co-Marketing Agreement With Histostem
Table 71: USD to Local Currency, South and Central America, Average Exchange Rate 2003-2010

1.2 List of Figures
Figure 1: In Vitro Diagnostics, Cross Country Comparison , USD Actual, 2003-2017
Figure 2: In Vitro Diagnostics, South and Central America, Overall Revenue ($m), USD Actual, 2003-2017
Figure 3: In Vitro Diagnostics, South and Central America, Cross-Category Analysis, 2003-2017
Figure 4: In Vitro Diagnostics, South and Central America, Overall Revenue ($m), USD Actual, Historic, 2003-2010
Figure 5: In Vitro Diagnostics, South and Central America, Overall Revenue ($m), USD Actual, Forecast, 2010-2017
Figure 6: In Vitro Diagnostics, South and Central America, Company share (%), 2010
Figure 7: In Vitro Diagnostics, Brazil, Overall Revenue ($m), USD Actual, 2003-2017
Figure 8: In Vitro Diagnostics, Brazil, Overall Revenue ($m), USD Actual, Historic, 2003-2010
Figure 9: In Vitro Diagnostics, Brazil, Overall Revenue ($m), USD Actual, Forecast, 2010-2017
Figure 10: In Vitro Diagnostics, Brazil, Company share (%), 2010
Figure 11: Clinical Chemistry, Brazil, Company share (%), 2010
Figure 12: Genetic Testing, Brazil, Company share (%), 2010
Figure 13: Haematology, Brazil, Company share (%), 2010
Figure 14: Histology And Cytology, Brazil, Company share (%), 2010
Figure 15: Immuno Chemistry, Brazil, Company share (%), 2010
Figure 16: Infectious Immunology, Brazil, Company share (%), 2010
Figure 17: Microbiology Culture, Brazil, Company share (%), 2010
Figure 18: In Vitro Diagnostics, Argentina, Overall Revenue ($m), USD Actual, 2003-2017
Figure 19: In Vitro Diagnostics, Argentina, Overall Revenue ($m), USD Actual, Historic, 2003-2010
Figure 20: In Vitro Diagnostics, Argentina, Overall Revenue ($m), USD Actual, Forecast, 2010-2017
Figure 21: In Vitro Diagnostics, Argentina, Company share (%), 2010
Figure 22: Clinical Chemistry, Argentina, Company share (%), 2010
Figure 23: Genetic Testing, Argentina, Company share (%), 2010
Figure 24: Haematology, Argentina, Company share (%), 2010
Figure 25: Histology And Cytology, Argentina, Company Share (%), 2010
Figure 26: Immuno Chemistry, Argentina, Company share (%), 2010
Figure 27: Infectious Immunology, Argentina, Company share (%), 2010
Figure 28: Microbiology Culture, Argentina, Company share (%), 2010
Figure 29: In Vitro Diagnostics, Mexico, Overall Revenue ($m), USD Actual, 2003-2017
Figure 30: In Vitro Diagnostics, Mexico, Overall Revenue ($m), USD Actual, Historic, 2003-2010
Figure 31: In Vitro Diagnostics, Mexico, Overall Revenue ($m), USD Actual, Forecast, 2010-2017
Figure 32: In Vitro Diagnostics, Mexico, Company Share (%), 2010
Figure 33: Clinical Chemistry, Mexico, Company Share (%), 2010
Figure 34: Genetic Testing, Mexico, Company Share (%), 2010
Figure 35: Haematology, Mexico, Company Share (%), 2010
Figure 36: Histology And Cytology, Mexico, Company Share (%), 2010
Figure 37: Immuno Chemistry, Mexico, Company Share (%), 2010
Figure 38: Infectious Immunology, Mexico, Company Share (%), 2010
Figure 39: Microbiology Culture, Mexico, Company Share (%), 2010
Figure 40: F. Hoffmann-La Roche Ltd., Company Share (%), South and Central America In Vitro Diagnostics Market, 2010
Figure 41: Siemens Healthcare, Company Share (%), South and Central America In Vitro Diagnostics Market, 2010
Figure 42: Abbott Laboratories, Company Share (%), South and Central America In Vitro Diagnostics Market, 2010
Figure 43: bioMerieux S.A., Company Share (%), South and Central America In Vitro Diagnostics Market, 2010
Figure 44: Bio-Rad Laboratories, Inc., Company Share (%), South and Central America In Vitro Diagnostics Market, 2010
Figure 45: Ortho-Clinical Diagnostics Inc., Company Share (%), South and Central America In Vitro Diagnostics Market, 2010

F. Hoffmann-La Roche Ltd.
Siemens Healthcare
Abbott Laboratories
bioMerieux S.A.
Bio-Rad Laboratories, Inc.
Ortho-Clinical Diagnostics Inc.
Beckman Coulter, Inc.
HORIBA, Ltd.
Becton, Dickinson and Company
Sysmex Corporation
Alere Inc.
DiaSorin S.p.A
Thermo Fisher Scientific Inc.
Phadia AB
Qiagen N.V.
Gen-Probe Incorporated
PerkinElmer, Inc.
Mindray Medical International Limited
Grifols, S.A.
DIAGNOSTICA STAGO, Inc.

Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos